Zebrafish Avatar to Develop Precision Breast Cancer Therapies

Anastasiadi, Z.; Lianos, G.D.; Ignatiadou, E.; Harissis, H.V.; Mitsis, M. Breast cancer in young women: an overview. Updates Surg., 2017, 69(3), 313-317.
[http://dx.doi.org/10.1007/s13304-017-0424-1] [PMID: 28260181]

Harbeck, N.; Penault-Llorca, F.; Cortes, J.; Gnant, M.; Houssami, N.; Poortmans, P.; Ruddy, K.; Tsang, J.; Cardoso, F. Breast cancer. Nat. Rev. Dis. Primers, 2019, 5(1), 66.
[http://dx.doi.org/10.1038/s41572-019-0111-2] [PMID: 31548545]

Caparica, R.; Brandão, M.; Piccart, M. Systemic treatment of patients with early breast cancer: recent updates and state of the art. Breast, 2019, 48(Suppl. 1), S7-S20.
[http://dx.doi.org/10.1016/S0960-9776(19)31115-4] [PMID: 31839166]

Taherian-Fard, A.; Srihari, S.; Ragan, M.A. Breast cancer classification: linking molecular mechanisms to disease prognosis. Brief. Bioinform., 2015, 16(3), 461-474.
[http://dx.doi.org/10.1093/bib/bbu020] [PMID: 24950687]

Cheang, M.C.; Martin, M.; Nielsen, T.O.; Prat, A.; Voduc, D.; Rodriguez-Lescure, A.; Ruiz, A.; Chia, S.; Shepherd, L.; Ruiz-Borrego, M.; Calvo, L.; Alba, E.; Carrasco, E.; Caballero, R.; Tu, D.; Pritchard, K.I.; Levine, M.N.; Bramwell, V.H.; Parker, J.; Bernard, P.S.; Ellis, M.J.; Perou, C.M.; Di Leo, A.; Carey, L.A. Defining breast cancer intrinsic subtypes by quantitative receptor expression. Oncologist, 2015, 20(5), 474-482.
[http://dx.doi.org/10.1634/theoncologist.2014-0372] [PMID: 25908555]

Perou, C.M.; Sørlie, T.; Eisen, M.B.; van de Rijn, M.; Jeffrey, S.S.; Rees, C.A.; Pollack, J.R.; Ross, D.T.; Johnsen, H.; Akslen, L.A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S.X.; Lønning, P.E.; Børresen-Dale, A.L.; Brown, P.O.; Botstein, D. Molecular portraits of human breast tumours. Nature, 2000, 406(6797), 747-752.
[http://dx.doi.org/10.1038/35021093] [PMID: 10963602]

Prat, A.; Pineda, E.; Adamo, B.; Galván, P.; Fernández, A.; Gaba, L.; Díez, M.; Viladot, M.; Arance, A.; Muñoz, M. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast, 2015, 24(Suppl. 2), S26-S35.
[http://dx.doi.org/10.1016/j.breast.2015.07.008] [PMID: 26253814]

Williams, C.; Lin, C.Y. Oestrogen receptors in breast cancer: basic mechanisms and clinical implications. Ecancermedicalscience, 2013, 7, 370.
[PMID: 24222786]

Mina, L.A.; Lim, S.; Bahadur, S.W.; Firoz, A.T. Immunotherapy for the treatment of breast cancer: emerging new data. Breast Cancer (Dove Med. Press), 2019, 11, 321-328.
[http://dx.doi.org/10.2147/BCTT.S184710] [PMID: 32099454]

Litton, J.K.; Rugo, H.S.; Ettl, J.; Hurvitz, S.A.; Gonçalves, A.; Lee, K.H.; Fehrenbacher, L.; Yerushalmi, R.; Mina, L.A.; Martin, M.; Roché, H.; Im, Y.H.; Quek, R.G.W.; Markova, D.; Tudor, I.C.; Hannah, A.L.; Eiermann, W.; Blum, J.L. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. N. Engl. J. Med., 2018, 379(8), 753-763.
[http://dx.doi.org/10.1056/NEJMoa1802905] [PMID: 30110579]

Robson, M.; Im, S.A.; Senkus, E.; Xu, B.; Domchek, S.M.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.; Conte, P. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N. Engl. J. Med., 2017, 377(6), 523-533.
[http://dx.doi.org/10.1056/NEJMoa1706450] [PMID: 28578601]

Zhao, S.; Zuo, W.J.; Shao, Z.M.; Jiang, Y.Z. Molecular subtypes and precision treatment of triple-negative breast cancer. Ann. Transl. Med., 2020, 8(7), 499.
[http://dx.doi.org/10.21037/atm.2020.03.194] [PMID: 32395543]

Costa, B.; Estrada, M.F.; Mendes, R.V.; Fior, R. Zebrafish avatars towards personalized medicine-A comparative review between avatar models. Cells, 2020, 9(2), E293.
[http://dx.doi.org/10.3390/cells9020293] [PMID: 31991800]

Fazio, M.; Ablain, J.; Chuan, Y.; Langenau, D.M.; Zon, L.I. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat. Rev. Cancer, 2020, 20(5), 263-273.
[http://dx.doi.org/10.1038/s41568-020-0252-3] [PMID: 32251397]

Wertman, J.; Veinotte, C.J.; Dellaire, G.; Berman, J.N. The zebrafish xenograft platform: evolution of a novel cancer model and preclinical screening tool. Adv. Exp. Med. Biol., 2016, 916, 289-314.
[http://dx.doi.org/10.1007/978-3-319-30654-4_13] [PMID: 27165359]

Astone, M.; Dankert, E.N.; Alam, S.K.; Hoeppner, L.H. Fishing for cures: the alLURE of using zebrafish to develop precision oncology therapies. NPJ Precis. Oncol., 2017, 1, 39.

Vacaru, A.M.; Unlu, G.; Spitzner, M.; Mione, M.; Knapik, E.W.; Sadler, K.C. In vivo cell biology in zebrafish - providing insights into vertebrate development and disease. J. Cell Sci., 2014, 127(Pt 3), 485-495.
[http://dx.doi.org/10.1242/jcs.140194] [PMID: 24481493]

Corallo, D.; Donadon, M.; Pantile, M.; Sidarovich, V.; Cocchi, S.; Ori, M.; De Sarlo, M.; Candiani, S.; Frasson, C.; Distel, M.; Quattrone, A.; Zanon, C.; Basso, G.; Tonini, G.P.; Aveic, S. LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors. Cell Death Differ., 2020, 27(4), 1225-1242.
[http://dx.doi.org/10.1038/s41418-019-0425-3] [PMID: 31601998]

Franceschi, S.; Corsinovi, D.; Lessi, F.; Tantillo, E.; Aretini, P.; Menicagli, M.; Scopelliti, C.; Civita, P.; Pasqualetti, F.; Naccarato, A.G.; Ori, M.; Mazzanti, C.M. Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression. EBioMedicine, 2018, 37, 56-67.
[http://dx.doi.org/10.1016/j.ebiom.2018.10.008] [PMID: 30314897]

Liu, J.; Zhou, Y.; Qi, X.; Chen, J.; Chen, W.; Qiu, G.; Wu, Z.; Wu, N. CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling. Hum. Genet., 2017, 136(1), 1-12.
[http://dx.doi.org/10.1007/s00439-016-1739-6] [PMID: 27807677]

Howe, K.; Clark, M.D.; Torroja, C.F.; Torrance, J.; Berthelot, C.; Muffato, M.; Collins, J.E.; Humphray, S.; McLaren, K.; Matthews, L.; McLaren, S.; Sealy, I.; Caccamo, M.; Churcher, C.; Scott, C.; Barrett, J.C.; Koch, R.; Rauch, G.J.; White, S.; Chow, W.; Kilian, B.; Quintais, L.T.; Guerra-Assunção, J.A.; Zhou, Y.; Gu, Y.; Yen, J.; Vogel, J.H.; Eyre, T.; Redmond, S.; Banerjee, R.; Chi, J.; Fu, B.; Langley, E.; Maguire, S.F.; Laird, G.K.; Lloyd, D.; Kenyon, E.; Donaldson, S.; Sehra, H.; Almeida-King, J.; Loveland, J.; Trevanion, S.; Jones, M.; Quail, M.; Willey, D.; Hunt, A.; Burton, J.; Sims, S.; McLay, K.; Plumb, B.; Davis, J.; Clee, C.; Oliver, K.; Clark, R.; Riddle, C.; Elliot, D.; Eliott, D.; Threadgold, G.; Harden, G.; Ware, D.; Begum, S.; Mortimore, B.; Mortimer, B.; Kerry, G.; Heath, P.; Phillimore, B.; Tracey, A.; Corby, N.; Dunn, M.; Johnson, C.; Wood, J.; Clark, S.; Pelan, S.; Griffiths, G.; Smith, M.; Glithero, R.; Howden, P.; Barker, N.; Lloyd, C.; Stevens, C.; Harley, J.; Holt, K.; Panagiotidis, G.; Lovell, J.; Beasley, H.; Henderson, C.; Gordon, D.; Auger, K.; Wright, D.; Collins, J.; Raisen, C.; Dyer, L.; Leung, K.; Robertson, L.; Ambridge, K.; Leongamornlert, D.; McGuire, S.; Gilderthorp, R.; Griffiths, C.; Manthravadi, D.; Nichol, S.; Barker, G.; Whitehead, S.; Kay, M.; Brown, J.; Murnane, C.; Gray, E.; Humphries, M.; Sycamore, N.; Barker, D.; Saunders, D.; Wallis, J.; Babbage, A.; Hammond, S.; Mashreghi-Mohammadi, M.; Barr, L.; Martin, S.; Wray, P.; Ellington, A.; Matthews, N.; Ellwood, M.; Woodmansey, R.; Clark, G.; Cooper, J.; Tromans, A.; Grafham, D.; Skuce, C.; Pandian, R.; Andrews, R.; Harrison, E.; Kimberley, A.; Garnett, J.; Fosker, N.; Hall, R.; Garner, P.; Kelly, D.; Bird, C.; Palmer, S.; Gehring, I.; Berger, A.; Dooley, C.M.; Raddatz, G.; Osoegawa, K.; Zhu, B.; Rapp, A.; Widaa, S.; Langford, C.; Yang, F.; Schuster, S.C.; Howe, K.; Clark, M.D.; Torroja, C.F.; Torrance, J.; Berthelot, C.; Muffato, M.; Collins, J.E.; Humphray, S.; McLaren, K.; Matthews, L.; McLaren, S.; Sealy, I.; Caccamo, M.; Churcher, C.; Scott, C.; Barrett, J.C.; Koch, R.; Rauch, G.J.; White, S.; Chow, W.; Kilian, B.; Quintais, L.T.; Guerra-Assunção, J.A.; Zhou, Y.; Gu, Y.; Yen, J.; Vogel, J.H.; Eyre, T.; Redmond, S.; Banerjee, R.; Chi, J.; Fu, B.; Langley, E.; Maguire, S.F.; Laird, G.K.; Lloyd, D.; Kenyon, E.; Donaldson, S.; Sehra, H.; Almeida-King, J.; Loveland, J.; Trevanion, S.; Jones, M.; Quail, M.; Willey, D.; Hunt, A.; Burton, J.; Sims, S.; McLay, K.; Plumb, B.; Davis, J.; Clee, C.; Oliver, K.; Clark, R.; Riddle, C.; Elliot, D.; Threadgold, G.; Harden, G.; Ware, D.; Begum, S.; Mortimore, B.; Kerry, G.; Heath, P.; Phillimore, B.; Tracey, A.; Corby, N.; Dunn, M.; Johnson, C.; Wood, J.; Clark, S.; Pelan, S.; Griffiths, G.; Smith, M.; Glithero, R.; Howden, P.; Barker, N.; Lloyd, C.; Stevens, C.; Harley, J.; Holt, K.; Panagiotidis, G.; Lovell, J.; Beasley, H.; Henderson, C.; Gordon, D.; Auger, K.; Wright, D.; Collins, J.; Raisen, C.; Dyer, L.; Leung, K.; Robertson, L.; Ambridge, K.; Leongamornlert, D.; McGuire, S.; Gilderthorp, R.; Griffiths, C.; Manthravadi, D.; Nichol, S.; Barker, G.; Whitehead, S.; Kay, M.; Brown, J.; Murnane, C.; Gray, E.; Humphries, M.; Sycamore, N.; Barker, D.; Saunders, D.; Wallis, J.; Babbage, A.; Hammond, S.; Mashreghi-Mohammadi, M.; Barr, L.; Martin, S.; Wray, P.; Ellington, A.; Matthews, N.; Ellwood, M.; Woodmansey, R.; Clark, G.; Cooper, J.; Tromans, A.; Grafham, D.; Skuce, C.; Pandian, R.; Andrews, R.; Harrison, E.; Kimberley, A.; Garnett, J.; Fosker, N.; Hall, R.; Garner, P.; Kelly, D.; Bird, C.; Palmer, S.; Gehring, I.; Berger, A.; Dooley, C.M.; Ersan-Ürün, Z.; Eser, C.; Geiger, H.; Geisler, M.; Karotki, L.; Kirn, A.; Konantz, J.; Konantz, M.; Oberländer, M.; Rudolph-Geiger, S.; Teucke, M.; Lanz, C.; Raddatz, G.; Osoegawa, K.; Zhu, B.; Rapp, A.; Widaa, S.; Langford, C.; Yang, F.; Schuster, S.C.; Carter, N.P.; Harrow, J.; Ning, Z.; Herrero, J.; Searle, S.M.; Enright, A.; Geisler, R.; Plasterk, R.H.; Lee, C.; Westerfield, M.; de Jong, P.J.; Zon, L.I.; Postlethwait, J.H.; Nüsslein-Volhard, C.; Hubbard, T.J.; Roest Crollius, H.; Rogers, J.; Stemple, D.L. The zebrafish reference genome sequence and its relationship to the human genome. Nature, 2013, 496(7446), 498-503.
[http://dx.doi.org/10.1038/nature12111] [PMID: 23594743]

Payne, E.; Look, T. Zebrafish modelling of leukaemias. Br. J. Haematol., 2009, 146(3), 247-256.
[http://dx.doi.org/10.1111/j.1365-2141.2009.07705.x] [PMID: 19466976]

Veinotte, C.J.; Dellaire, G.; Berman, J.N. Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis. Model. Mech., 2014, 7(7), 745-754.
[http://dx.doi.org/10.1242/dmm.015784] [PMID: 24973744]

Corallo, D.; Candiani, S.; Ori, M.; Aveic, S.; Tonini, G.P. The zebrafish as a model for studying neuroblastoma. Cancer Cell Int., 2016, 16, 82.
[http://dx.doi.org/10.1186/s12935-016-0360-z] [PMID: 27822138]

Lee, Y.; Grill, S.; Sanchez, A.; Murphy-Ryan, M.; Poss, K.D. FGF signaling instructs position-dependent growth rate during zebrafish fin regeneration. Development, 2005, 132(23), 5173-5183.
[http://dx.doi.org/10.1242/dev.02101] [PMID: 16251209]

Yan, C.; Brunson, D.C.; Tang, Q.; Do, D.; Iftimia, N.A.; Moore, J.C.; Hayes, M.N.; Welker, A.M.; Garcia, E.G.; Dubash, T.D.; Hong, X.; Drapkin, B.J.; Myers, D.T.; Phat, S.; Volorio, A.; Marvin, D.L.; Ligorio, M.; Dershowitz, L.; McCarthy, K.M.; Karabacak, M.N.; Fletcher, J.A.; Sgroi, D.C.; Iafrate, J.A.; Maheswaran, S.; Dyson, N.J.; Haber, D.A.; Rawls, J.F.; Langenau, D.M. Visualizing engrafted human cancer and therapy responses in immunodeficient zebrafish. Cell, 2019, 177(7), 1903-1914.
[http://dx.doi.org/10.1016/j.cell.2019.04.004] [PMID: 31031007]

Letrado, P.; de Miguel, I.; Lamberto, I.; Díez-Martínez, R.; Oyarzabal, J. Zebrafish: speeding up the cancer drug discovery process. Cancer Res., 2018, 78(21), 6048-6058.
[http://dx.doi.org/10.1158/0008-5472.CAN-18-1029] [PMID: 30327381]

Mathias, J.R.; Dodd, M.E.; Walters, K.B.; Yoo, S.K.; Ranheim, E.A.; Huttenlocher, A. Characterization of zebrafish larval inflammatory macrophages. Dev. Comp. Immunol., 2009, 33(11), 1212-1217.
[http://dx.doi.org/10.1016/j.dci.2009.07.003] [PMID: 19619578]

Ellett, F.; Pase, L.; Hayman, J.W.; Andrianopoulos, A.; Lieschke, G.J. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood, 2011, 117(4), e49-e56.
[http://dx.doi.org/10.1182/blood-2010-10-314120] [PMID: 21084707]

He, S.; Lamers, G.E.; Beenakker, J.W.; Cui, C.; Ghotra, V.P.; Danen, E.H.; Meijer, A.H.; Spaink, H.P.; Snaar-Jagalska, B.E. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J. Pathol., 2012, 227(4), 431-445.
[http://dx.doi.org/10.1002/path.4013] [PMID: 22374800]

Kim, I.S.; Heilmann, S.; Kansler, E.R.; Zhang, Y.; Zimmer, M.; Ratnakumar, K.; Bowman, R.L.; Simon-Vermot, T.; Fennell, M.; Garippa, R.; Lu, L.; Lee, W.; Hollmann, T.; Xavier, J.B.; White, R.M. Microenvironment-derived factors driving metastatic plasticity in melanoma. Nat. Commun., 2017, 8, 14343.
[http://dx.doi.org/10.1038/ncomms14343] [PMID: 28181494]

Patton, E.E.; Zon, L.I. The art and design of genetic screens: zebrafish. Nat. Rev. Genet., 2001, 2(12), 956-966.
[http://dx.doi.org/10.1038/35103567] [PMID: 11733748]

White, R.M.; Sessa, A.; Burke, C.; Bowman, T.; LeBlanc, J.; Ceol, C.; Bourque, C.; Dovey, M.; Goessling, W.; Burns, C.E.; Zon, L.I. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell, 2008, 2(2), 183-189.
[http://dx.doi.org/10.1016/j.stem.2007.11.002] [PMID: 18371439]

White, R.; Rose, K.; Zon, L. Zebrafish cancer: the state of the art and the path forward. Nat. Rev. Cancer, 2013, 13(9), 624-636.
[http://dx.doi.org/10.1038/nrc3589] [PMID: 23969693]

Nguyen-Chi, M.; Laplace-Builhe, B.; Travnickova, J.; Luz-Crawford, P.; Tejedor, G.; Phan, Q.T.; Duroux-Richard, I.; Levraud, J.P.; Kissa, K.; Lutfalla, G.; Jorgensen, C.; Djouad, F. Identification of polarized macrophage subsets in zebrafish. eLife, 2015, 4,e07288.
[http://dx.doi.org/10.7554/eLife.07288] [PMID: 26154973]

Lawson, N.D.; Weinstein, B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol., 2002, 248(2), 307-318.
[http://dx.doi.org/10.1006/dbio.2002.0711] [PMID: 12167406]

Gabellini, C.; Gómez-Abenza, E.; Ibáñez-Molero, S.; Tupone, M.G.; Pérez-Oliva, A.B.; de Oliveira, S.; Del Bufalo, D.; Mulero, V. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model. Int. J. Cancer, 2018, 142(3), 584-596.
[http://dx.doi.org/10.1002/ijc.31075] [PMID: 28949016]

Roh-Johnson, M.; Shah, A.N.; Stonick, J.A.; Poudel, K.R.; Kargl, J.; Yang, G.H.; di Martino, J.; Hernandez, R.E.; Gast, C.E.; Zarour, L.R.; Antoku, S.; Houghton, A.M.; Bravo-Cordero, J.J.; Wong, M.H.; Condeelis, J.; Moens, C.B. Macrophage-dependent cytoplasmic transfer during melanoma invasion in vivo. Dev. Cell, 2017, 43(5), 549-562.
[http://dx.doi.org/10.1016/j.devcel.2017.11.003] [PMID: 29207258]

Konantz, M.; Balci, T.B.; Hartwig, U.F.; Dellaire, G.; André, M.C.; Berman, J.N.; Lengerke, C. Zebrafish xenografts as a tool for in vivo studies on human cancer. Ann. N. Y. Acad. Sci., 2012, 1266, 124-137.
[http://dx.doi.org/10.1111/j.1749-6632.2012.06575.x] [PMID: 22901264]

Paul, S.M.; Mytelka, D.S.; Dunwiddie, C.T.; Persinger, C.C.; Munos, B.H.; Lindborg, S.R.; Schacht, A.L. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat. Rev. Drug Discov., 2010, 9(3), 203-214.
[http://dx.doi.org/10.1038/nrd3078] [PMID: 20168317]

Weaver, V.M.; Lelièvre, S.; Lakins, J.N.; Chrenek, M.A.; Jones, J.C.; Giancotti, F.; Werb, Z.; Bissell, M.J. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell, 2002, 2(3), 205-216.
[http://dx.doi.org/10.1016/S1535-6108(02)00125-3] [PMID: 12242153]

Burdall, S.E.; Hanby, A.M.; Lansdown, M.R.; Speirs, V. Breast cancer cell lines: friend or foe? Breast Cancer Res., 2003, 5(2), 89-95.
[http://dx.doi.org/10.1186/bcr577] [PMID: 12631387]

Kondo, J.; Inoue, M. Application of cancer organoid model for drug screening and personalized therapy. Cells, 2019, 8(5),E470.
[http://dx.doi.org/10.3390/cells8050470] [PMID: 31108870]

Kersten, K.; de Visser, K.E.; van Miltenburg, M.H.; Jonkers, J. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol. Med., 2017, 9(2), 137-153.
[http://dx.doi.org/10.15252/emmm.201606857] [PMID: 28028012]

Geisler, R.; Köhler, A.; Dickmeis, T.; Strähle, U. Archiving of zebrafish lines can reduce animal experiments in biomedical research. EMBO Rep., 2017, 18(1), 1-2.
[http://dx.doi.org/10.15252/embr.201643561] [PMID: 27979973]

Casey, M.J.; Stewart, R.A. Pediatric cancer models in zebrafish. Trends Cancer, 2020, 6(5), 407-418.
[http://dx.doi.org/10.1016/j.trecan.2020.02.006] [PMID: 32348736]

Goessling, W.; North, T.E.; Zon, L.I. New waves of discovery: modeling cancer in zebrafish. J. Clin. Oncol., 2007, 25(17), 2473-2479.
[http://dx.doi.org/10.1200/JCO.2006.08.9821] [PMID: 17557959]

Zhang, F.; Qin, W.; Zhang, J.P.; Hu, C.Q. Antibiotic toxicity and absorption in zebrafish using liquid chromatography-tandem mass spectrometry. PLoS One, 2015, 10(5),e0124805.
[http://dx.doi.org/10.1371/journal.pone.0124805] [PMID: 25938774]

Brown, H.K.; Schiavone, K.; Tazzyman, S.; Heymann, D.; Chico, T.J. Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opin. Drug Discov., 2017, 12(4), 379-389.
[http://dx.doi.org/10.1080/17460441.2017.1297416] [PMID: 28277839]

Wang, C.; Tao, W.; Wang, Y.; Bikow, J.; Lu, B.; Keating, A.; Verma, S.; Parker, T.G.; Han, R.; Wen, X.Y. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur. Urol., 2010, 58(3), 418-426.
[http://dx.doi.org/10.1016/j.eururo.2010.05.024] [PMID: 20605315]

MacRae, C.A.; Peterson, R.T. Zebrafish as tools for drug discovery. Nat. Rev. Drug Discov., 2015, 14(10), 721-731.
[http://dx.doi.org/10.1038/nrd4627] [PMID: 26361349]

Dyballa, S.; Miñana, R.; Rubio-Brotons, M.; Cornet, C.; Pederzani, T.; Escaramis, G.; Garcia-Serna, R.; Mestres, J.; Terriente, J. Comparison of zebrafish larvae and hiPSC cardiomyocytes for predicting drug induced cardiotoxicity in humans. Toxicol. Sci., 2019.,kfz165.
[http://dx.doi.org/10.1093/toxsci/kfz165] [PMID: 31359052]

Tessadori, F.; van Weerd, J.H.; Burkhard, S.B.; Verkerk, A.O.; de Pater, E.; Boukens, B.J.; Vink, A.; Christoffels, V.M.; Bakkers, J. Identification and functional characterization of cardiac pacemaker cells in zebrafish. PLoS One, 2012, 7(10),e47644.
[http://dx.doi.org/10.1371/journal.pone.0047644] [PMID: 23077655]

Kithcart, A.; MacRae, C.A. Using zebrafish for high-throughput screening of novel cardiovascular drugs. JACC Basic Transl. Sci., 2017, 2(1), 1-12.
[http://dx.doi.org/10.1016/j.jacbts.2017.01.004] [PMID: 30167552]

Milan, D.J.; Peterson, T.A.; Ruskin, J.N.; Peterson, R.T.; MacRae, C.A. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation, 2003, 107(10), 1355-1358.
[http://dx.doi.org/10.1161/01.CIR.0000061912.88753.87] [PMID: 12642353]

Zhu, J.J.; Xu, Y.Q.; He, J.H.; Yu, H.P.; Huang, C.J.; Gao, J.M.; Dong, Q.X.; Xuan, Y.X.; Li, C.Q. Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish. J. Appl. Toxicol., 2014, 34(2), 139-148.
[http://dx.doi.org/10.1002/jat.2843] [PMID: 23307606]

Driessen, M.; Vitins, A.P.; Pennings, J.L.; Kienhuis, A.S.; Water, B.; van der Ven, L.T. A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen. Toxicol. Lett., 2015, 232(2), 403-412.
[http://dx.doi.org/10.1016/j.toxlet.2014.11.020] [PMID: 25448281]

Ducharme, N.A.; Reif, D.M.; Gustafsson, J.A.; Bondesson, M. Comparison of toxicity values across zebrafish early life stages and mammalian studies: implications for chemical testing. Reprod. Toxicol., 2015, 55, 3-10.
[http://dx.doi.org/10.1016/j.reprotox.2014.09.005] [PMID: 25261610]

Truong, L.; Reif, D.M.; St Mary, L.; Geier, M.C.; Truong, H.D.; Tanguay, R.L. Multidimensional in vivo hazard assessment using zebrafish. Toxicol. Sci., 2014, 137(1), 212-233.
[http://dx.doi.org/10.1093/toxsci/kft235] [PMID: 24136191]

Khalili, A.; Rezai, P. Microfluidic devices for embryonic and larval zebrafish studies. Brief. Funct. Genomics, 2019, 18(6), 419-432.
[http://dx.doi.org/10.1093/bfgp/elz006] [PMID: 31034029]

Cornet, C.; Dyballa, S.; Terriente, J.; Di Giacomo, V. ZeOncoTest: refining and automating the zebrafish xenograft model for drug discovery in cancer. Pharmaceuticals (Basel), 2019, 13(1), E1.
[http://dx.doi.org/10.3390/ph13010001] [PMID: 31878274]

North, T.E.; Goessling, W.; Walkley, C.R.; Lengerke, C.; Kopani, K.R.; Lord, A.M.; Weber, G.J.; Bowman, T.V.; Jang, I.H.; Grosser, T.; Fitzgerald, G.A.; Daley, G.Q.; Orkin, S.H.; Zon, L.I. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature, 2007, 447(7147), 1007-1011.
[http://dx.doi.org/10.1038/nature05883] [PMID: 17581586]

White, R.M.; Cech, J.; Ratanasirintrawoot, S.; Lin, C.Y.; Rahl, P.B.; Burke, C.J.; Langdon, E.; Tomlinson, M.L.; Mosher, J.; Kaufman, C.; Chen, F.; Long, H.K.; Kramer, M.; Datta, S.; Neuberg, D.; Granter, S.; Young, R.A.; Morrison, S.; Wheeler, G.N.; Zon, L.I. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature, 2011, 471(7339), 518-522.
[http://dx.doi.org/10.1038/nature09882] [PMID: 21430780]

Yeh, J.R.; Munson, K.M.; Chao, Y.L.; Peterson, Q.P.; Macrae, C.A.; Peterson, R.T. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development, 2008, 135(2), 401-410.
[http://dx.doi.org/10.1242/dev.008904] [PMID: 18156164]

Zhang, Y.; Wang, J.; Wheat, J.; Chen, X.; Jin, S.; Sadrzadeh, H.; Fathi, A.T.; Peterson, R.T.; Kung, A.L.; Sweetser, D.A.; Yeh, J.R. AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway. Blood, 2013, 121(24), 4906-4916.
[http://dx.doi.org/10.1182/blood-2012-08-447763] [PMID: 23645839]

Hason, M.; Bartůněk, P. Zebrafish models of cancer-new insights on modeling human cancer in a non-mammalian vertebrate. Genes (Basel), 2019, 10(11),E935.
[http://dx.doi.org/10.3390/genes10110935] [PMID: 31731811]

Park, J.H.; Williams, D.R.; Lee, J.H.; Lee, S.D.; Lee, J.H.; Ko, H.; Lee, G.E.; Kim, S.; Lee, J.M.; Abdelrahman, A.; Müller, C.E.; Jung, D.W.; Kim, Y.C. Potent suppressive effects of 1-piperidinylimidazole based novel P2X7 receptor antagonists on cancer cell migration and invasion. J. Med. Chem., 2016, 59(16), 7410-7430.
[http://dx.doi.org/10.1021/acs.jmedchem.5b01690] [PMID: 27427902]

Xie, X.; Tang, S.C.; Cai, Y.; Pi, W.; Deng, L.; Wu, G.; Chavanieu, A.; Teng, Y. Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1. Oncotarget, 2016, 7(36), 58111-58120.
[http://dx.doi.org/10.18632/oncotarget.11185] [PMID: 27517156]

Ghotra, V.P.; He, S.; de Bont, H.; van der Ent, W.; Spaink, H.P.; van de Water, B.; Snaar-Jagalska, B.E.; Danen, E.H. Automated whole animal bio-imaging assay for human cancer dissemination. PLoS One, 2012, 7(2),e31281.
[http://dx.doi.org/10.1371/journal.pone.0031281] [PMID: 22347456]

Drabsch, Y.; He, S.; Zhang, L.; Snaar-Jagalska, B.E.; ten Dijke, P. Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model. Breast Cancer Res., 2013, 15(6), R106.
[http://dx.doi.org/10.1186/bcr3573] [PMID: 24196484]

Naber, H.P.; Drabsch, Y.; Snaar-Jagalska, B.E.; ten Dijke, P.; van Laar, T. Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion. Biochem. Biophys. Res. Commun., 2013, 435(1), 58-63.
[http://dx.doi.org/10.1016/j.bbrc.2013.04.037] [PMID: 23618854]

Truong, H.H.; Xiong, J.; Ghotra, V.P.; Nirmala, E.; Haazen, L.; Le Dévédec, S.E.; Balcioğlu, H.E.; He, S.; Snaar-Jagalska, B.E.; Vreugdenhil, E.; Meerman, J.H.; van de Water, B.; Danen, E.H. β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. Sci. Signal., 2014, 7(312), ra15.
[http://dx.doi.org/10.1126/scisignal.2004751] [PMID: 24518294]

Tulotta, C.; Stefanescu, C.; Beletkaia, E.; Bussmann, J.; Tarbashevich, K.; Schmidt, T.; Snaar-Jagalska, B.E. Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model. Dis. Model. Mech., 2016, 9(2), 141-153.
[http://dx.doi.org/10.1242/dmm.023275] [PMID: 26744352]

Tulotta, C.; Stefanescu, C.; Chen, Q.; Torraca, V.; Meijer, A.H.; Snaar-Jagalska, B.E. CXCR4 signaling regulates metastatic onset by controlling neutrophil motility and response to malignant cells. Sci. Rep., 2019, 9(1), 2399.
[http://dx.doi.org/10.1038/s41598-019-38643-2] [PMID: 30787324]

Yang, Y.; Hao, E.; Pan, X.; Tan, D.; Du, Z.; Xie, J.; Hou, X.; Deng, J.; Wei, K. Gomisin M2 from Baizuan suppresses breast cancer stem cell proliferation in a zebrafish xenograft model. Aging (Albany NY), 2019, 11(19), 8347-8361.
[http://dx.doi.org/10.18632/aging.102323] [PMID: 31612865]

Golbaghi, G.; Pitard, I.; Lucas, M.; Haghdoost, M.M.; de Los Santos, Y.L.; Doucet, N.; Patten, S.A.; Sanderson, J.T.; Castonguay, A. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos. Eur. J. Med. Chem., 2020, 188,112030.
[http://dx.doi.org/10.1016/j.ejmech.2019.112030] [PMID: 31945643]

Asokan, N.; Daetwyler, S.; Bernas, S.N.; Schmied, C.; Vogler, S.; Lambert, K.; Wobus, M.; Wermke, M.; Kempermann, G.; Huisken, J.; Brand, M.; Bornhäuser, M. Long-term in vivo imaging reveals tumor-specific dissemination and captures host tumor interaction in zebrafish xenografts. Sci. Rep., 2020, 10(1), 13254.
[http://dx.doi.org/10.1038/s41598-020-69956-2] [PMID: 32764590]

Yao, D.; Li, C.; Jiang, J.; Huang, J.; Wang, J.; He, Z.; Zhang, J. Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer. Eur. J. Med. Chem., 2020, 205,112648.
[http://dx.doi.org/10.1016/j.ejmech.2020.112648] [PMID: 32791401]

Eguiara, A.; Holgado, O.; Beloqui, I.; Abalde, L.; Sanchez, Y.; Callol, C.; Martin, A.G. Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification. Cell Cycle, 2011, 10(21), 3751-3757.
[http://dx.doi.org/10.4161/cc.10.21.17921] [PMID: 22033190]

Schaefer, T.; Wang, H.; Mir, P.; Konantz, M.; Pereboom, T.C.; Paczulla, A.M.; Merz, B.; Fehm, T.; Perner, S.; Rothfuss, O.C.; Kanz, L.; Schulze-Osthoff, K.; Lengerke, C. Molecular and functional interactions between AKT and SOX2 in breast carcinoma. Oncotarget, 2015, 6(41), 43540-43556.
[http://dx.doi.org/10.18632/oncotarget.6183] [PMID: 26498353]

Lee, J.K.; Liu, Z.; Sa, J.K.; Shin, S.; Wang, J.; Bordyuh, M.; Cho, H.J.; Elliott, O.; Chu, T.; Choi, S.W.; Rosenbloom, D.I.S.; Lee, I.H.; Shin, Y.J.; Kang, H.J.; Kim, D.; Kim, S.Y.; Sim, M.H.; Kim, J.; Lee, T.; Seo, Y.J.; Shin, H.; Lee, M.; Kim, S.H.; Kwon, Y.J.; Oh, J.W.; Song, M.; Kim, M.; Kong, D.S.; Choi, J.W.; Seol, H.J.; Lee, J.I.; Kim, S.T.; Park, J.O.; Kim, K.M.; Song, S.Y.; Lee, J.W.; Kim, H.C.; Lee, J.E.; Choi, M.G.; Seo, S.W.; Shim, Y.M.; Zo, J.I.; Jeong, B.C.; Yoon, Y.; Ryu, G.H.; Kim, N.K.D.; Bae, J.S.; Park, W.Y.; Lee, J.; Verhaak, R.G.W.; Iavarone, A.; Lee, J.; Rabadan, R.; Nam, D.H. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. Nat. Genet., 2018, 50(10), 1399-1411.
[http://dx.doi.org/10.1038/s41588-018-0209-6] [PMID: 30262818]

Hidalgo, M.; Amant, F.; Biankin, A.V.; Budinská, E.; Byrne, A.T.; Caldas, C.; Clarke, R.B.; de Jong, S.; Jonkers, J.; Mælandsmo, G.M.; Roman-Roman, S.; Seoane, J.; Trusolino, L.; Villanueva, A. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov., 2014, 4(9), 998-1013.
[http://dx.doi.org/10.1158/2159-8290.CD-14-0001] [PMID: 25185190]

Malaney, P.; Nicosia, S.V.; Davé, V. One mouse, one patient paradigm: new avatars of personalized cancer therapy. Cancer Lett., 2014, 344(1), 1-12.
[http://dx.doi.org/10.1016/j.canlet.2013.10.010] [PMID: 24157811]

Rygaard, J.; Povlsen, C.O. Heterotransplantation of a human malignant tumour to “Nude” mice. Acta Pathol. Microbiol. Scand., 1969, 77(4), 758-760.
[http://dx.doi.org/10.1111/j.1699-0463.1969.tb04520.x] [PMID: 5383844]

Flanagan, S.P. ‘Nude’, a new hairless gene with pleiotropic effects in the mouse. Genet. Res., 1966, 8(3), 295-309.
[http://dx.doi.org/10.1017/S0016672300010168] [PMID: 5980117]

Mercatali, L.; La Manna, F.; Groenewoud, A.; Casadei, R.; Recine, F.; Miserocchi, G.; Pieri, F.; Liverani, C.; Bongiovanni, A.; Spadazzi, C.; de Vita, A.; van der Pluijm, G.; Giorgini, A.; Biagini, R.; Amadori, D.; Ibrahim, T.; Snaar-Jagalska, E. Development of a Patient-Derived Xenograft (PDX) of breast cancer bone metastasis in a zebrafish model. Int. J. Mol. Sci., 2016, 17(8),E1375.
[http://dx.doi.org/10.3390/ijms17081375] [PMID: 27556456]

Fior, R.; Póvoa, V.; Mendes, R.V.; Carvalho, T.; Gomes, A.; Figueiredo, N.; Ferreira, M.G. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc. Natl. Acad. Sci. USA, 2017, 114(39), E8234-E8243.
[http://dx.doi.org/10.1073/pnas.1618389114] [PMID: 28835536]

Gacha-Garay, M.J.; Niño-Joya, A.F.; Bolaños, N.I.; Abenoza, L.; Quintero, G.; Ibarra, H.; Gonzalez, J.M.; Akle, V.; Garavito-Aguilar, Z.V. Pilot study of an integrative new tool for studying clinical outcome discrimination in acute leukemia. Front. Oncol., 2019, 9, 245.
[http://dx.doi.org/10.3389/fonc.2019.00245] [PMID: 31024847]

Lee, L.M.; Seftor, E.A.; Bonde, G.; Cornell, R.A.; Hendrix, M.J. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev. Dyn., 2005, 233(4), 1560-1570.
[http://dx.doi.org/10.1002/dvdy.20471] [PMID: 15968639]

Smith, S.J.; Wilson, M.; Ward, J.H.; Rahman, C.V.; Peet, A.C.; Macarthur, D.C.; Rose, F.R.; Grundy, R.G.; Rahman, R. Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition. PLoS One, 2012, 7(12),e52335.
[http://dx.doi.org/10.1371/journal.pone.0052335] [PMID: 23272238]

Inoue, T.; Terada, N.; Kobayashi, T.; Ogawa, O. Patient-derived xenografts as in vivo models for research in urological malignancies. Nat. Rev. Urol., 2017, 14(5), 267-283.
[http://dx.doi.org/10.1038/nrurol.2017.19] [PMID: 28248952]

Marques, I.J.; Weiss, F.U.; Vlecken, D.H.; Nitsche, C.; Bakkers, J.; Lagendijk, A.K.; Partecke, L.I.; Heidecke, C.D.; Lerch, M.M.; Bagowski, C.P. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer, 2009, 9, 128.
[http://dx.doi.org/10.1186/1471-2407-9-128] [PMID: 19400945]

Bentley, V.L.; Veinotte, C.J.; Corkery, D.P.; Pinder, J.B.; LeBlanc, M.A.; Bedard, K.; Weng, A.P.; Berman, J.N.; Dellaire, G. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica, 2015, 100(1), 70-76.
[http://dx.doi.org/10.3324/haematol.2014.110742] [PMID: 25281505]

Di Franco, G.; Usai, A.; Funel, N.; Palmeri, M.; Montesanti, I.E.R.; Bianchini, M.; Gianardi, D.; Furbetta, N.; Guadagni, S.; Vasile, E.; Falcone, A.; Pollina, L.E.; Raffa, V.; Morelli, L. Use of zebrafish embryos as avatar of patients with pancreatic cancer: a new xenotransplantation model towards personalized medicine. World J. Gastroenterol., 2020, 26(21), 2792-2809.
[http://dx.doi.org/10.3748/wjg.v26.i21.2792] [PMID: 32550755]

Wu, J.Q.; Zhai, J.; Li, C.Y.; Tan, A.M.; Wei, P.; Shen, L.Z.; He, M.F. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. J. Exp. Clin. Cancer Res., 2017, 36(1), 160.
[http://dx.doi.org/10.1186/s13046-017-0631-0] [PMID: 29141689]

Vitale, G.; Gaudenzi, G.; Dicitore, A.; Cotelli, F.; Ferone, D.; Persani, L. Zebrafish as an innovative model for neuroendocrine tumors. Endocr. Relat. Cancer, 2014, 21(1), R67-R83.
[http://dx.doi.org/10.1530/ERC-13-0388] [PMID: 24292602]

Usai, A.; Di Franco, G.; Colucci, P.; Pollina, L.E.; Vasile, E.; Funel, N.; Palmeri, M.; Dente, L.; Falcone, A.; Morelli, L.; Raffa, V. A model of a zebrafish avatar for co-clinical trials. Cancers (Basel), 2020, 12(3),E677.
[http://dx.doi.org/10.3390/cancers12030677] [PMID: 32183229]

Strähle, U.; Scholz, S.; Geisler, R.; Greiner, P.; Hollert, H.; Rastegar, S.; Schumacher, A.; Selderslaghs, I.; Weiss, C.; Witters, H.; Braunbeck, T. Zebrafish embryos as an alternative to animal experiments-a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod. Toxicol., 2012, 33(2), 128-132.
[http://dx.doi.org/10.1016/j.reprotox.2011.06.121] [PMID: 21726626]

Hill, D.; Chen, L.; Snaar-Jagalska, E.; Chaudhry, B. Embryonic zebrafish xenograft assay of human cancer metastasis. F1000 Res., 2018, 7, 1682.
[http://dx.doi.org/10.12688/f1000research.16659.2] [PMID: 30473782]

Lal, S.; La Du, J.; Tanguay, R.L.; Greenwood, J.A. Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment. J. Neurosci. Res., 2012, 90(4), 769-781.
[http://dx.doi.org/10.1002/jnr.22794] [PMID: 22183788]

Byrne, A.T.; Alférez, D.G.; Amant, F.; Annibali, D.; Arribas, J.; Biankin, A.V.; Bruna, A.; Budinská, E.; Caldas, C.; Chang, D.K.; Clarke, R.B.; Clevers, H.; Coukos, G.; Dangles-Marie, V.; Eckhardt, S.G.; Gonzalez-Suarez, E.; Hermans, E.; Hidalgo, M.; Jarzabek, M.A.; de Jong, S.; Jonkers, J.; Kemper, K.; Lanfrancone, L.; Mælandsmo, G.M.; Marangoni, E.; Marine, J.C.; Medico, E.; Norum, J.H.; Palmer, H.G.; Peeper, D.S.; Pelicci, P.G.; Piris-Gimenez, A.; Roman-Roman, S.; Rueda, O.M.; Seoane, J.; Serra, V.; Soucek, L.; Vanhecke, D.; Villanueva, A.; Vinolo, E.; Bertotti, A.; Trusolino, L. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat. Rev. Cancer, 2017, 17(4), 254-268.
[http://dx.doi.org/10.1038/nrc.2016.140] [PMID: 28104906]

Costa, B.; Ferreira, S.; Póvoa, V.; Cardoso, M.J.; Vieira, S.; Stroom, J.; Fidalgo, P.; Rio-Tinto, R.; Figueiredo, N.; Parés, O.; Greco, C.; Ferreira, M.G.; Fior, R. Developments in zebrafish avatars as radiotherapy sensitivity reporters - towards personalized medicine. EBioMedicine, 2020, 51,102578.
[http://dx.doi.org/10.1016/j.ebiom.2019.11.039] [PMID: 31862441]

Yan, C.; Yang, Q.; Do, D.; Brunson, D.C.; Langenau, D.M. Adult immune compromised zebrafish for xenograft cell transplantation studies. EBioMedicine, 2019, 47, 24-26.
[http://dx.doi.org/10.1016/j.ebiom.2019.08.016] [PMID: 31416720]

Rebelo de Almeida, C.; Mendes, R.V.; Pezzarossa, A.; Gago, J.; Carvalho, C.; Alves, A.; Nunes, V.; Brito, M.J.; Cardoso, M.J.; Ribeiro, J.; Cardoso, F.; Ferreira, M.G.; Fior, R. Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy. Commun. Biol., 2020, 3(1), 299.
[http://dx.doi.org/10.1038/s42003-020-1015-0] [PMID: 32523131]

Varanda, A.B.; Martins-Logrado, A.; Ferreira, M.G.; Fior, R. Zebrafish xenografts unveil sensitivity to olaparib beyond BRCA status. Cancers (Basel), 2020, 12(7),E1769.
[http://dx.doi.org/10.3390/cancers12071769] [PMID: 32630796]

Cabezas-Sáinz, P.; Pensado-López, A.; Sáinz, B., Jr; Sánchez, L. Modeling cancer using zebrafish xenografts: drawbacks for mimicking the human microenvironment. Cells, 2020, 9(9),E1978.
[http://dx.doi.org/10.3390/cells9091978] [PMID: 32867288]